Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Gt Biopharma Inc stock (Gt Biopharma Inc)

Buy Gt Biopharma Inc stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

GT Biopharma, a company that develops novel immuno-oncology biopharmaceutical drugs, is looking to be listed on the Nasdaq. The company is currently listed on the Over-the-Counter Markets under the ticker symbol "GTBP." It hopes to trade on the Nasdaq under the same ticker symbol.

Our top picks for where to buy GT Biopharma stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

How to buy Gt Biopharma Inc stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – GTBP. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Gt Biopharma Inc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
Robinhood
Finder Score: 4.5 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Gt Biopharma Inc stock price (NASDAQ: GTBP)

Use our graph to track the performance of GTBP stocks over time.

Gt Biopharma Inc shares at a glance

Information last updated 2024-10-24.
Latest market close$3.33
52-week range$1.92 - $10.66
50-day moving average $2.16
200-day moving average $3.50
Wall St. target price$150.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-7.76

Is it a good time to buy Gt Biopharma Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Gt Biopharma Inc price performance over time

Historical closes compared with the close of $3.3 from 2024-10-28

1 week (2024-10-23) 11.89%
1 month (2024-10-01) 48.65%
3 months (2024-07-31) 26.44%
6 months (2024-05-01) 4.10%
1 year (2023-10-31) 1,224.77%
2 years (2022-10-31) 77.42%
3 years (2021-10-29) 6.46
5 years (2019-10-31) 14.52%

Gt Biopharma Inc financials

Gross profit TTM $0
Return on assets TTM -60.59%
Return on equity TTM -131.48%
Profit margin 0%
Book value $2.47
Market Capitalization $6.7 million

TTM: trailing 12 months

Gt Biopharma Inc share dividends

We're not expecting Gt Biopharma Inc to pay a dividend over the next 12 months.

You may also wish to consider:

Have Gt Biopharma Inc's shares ever split?

Gt Biopharma Inc's shares were split on a 1:30 basis on 4 February 2024 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Gt Biopharma Inc shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Gt Biopharma Inc shares which in turn could have impacted Gt Biopharma Inc's share price.

Gt Biopharma Inc share price volatility

Over the last 12 months, Gt Biopharma Inc's shares have ranged in value from as little as $1.9201 up to $10.6599. A popular way to gauge a stock's volatility is its "beta".

GTBP.US volatility(beta: 0.62)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Gt Biopharma Inc's is 0.624. This would suggest that Gt Biopharma Inc's shares are less volatile than average (for this exchange).

To put Gt Biopharma Inc's beta into context you can compare it against those of similar companies.

Gt Biopharma Inc overview

GT Biopharma, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 (GTB-3550) TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc.

Frequently asked questions

null
What percentage of Gt Biopharma Inc is owned by insiders or institutions?
Currently 12.148% of Gt Biopharma Inc shares are held by insiders and 60.094% by institutions.
How many people work for Gt Biopharma Inc?
Latest data suggests 2 work at Gt Biopharma Inc.
When does the fiscal year end for Gt Biopharma Inc?
Gt Biopharma Inc's fiscal year ends in December.
Where is Gt Biopharma Inc based?
Gt Biopharma Inc's address is: 8000 Marina Boulevard, Brisbane, CA, United States, 94005
What is Gt Biopharma Inc's ISIN number?
Gt Biopharma Inc's international securities identification number is: US36254L2097

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site